Business Description
New Horizon Health Ltd
ISIN : KYG6485S1021
Share Class Description:
HKSE:06606: Ordinary SharesCompare
Compare
Traded in other countries / regions
06606.Hong Kong6YZ.Germany IPO Date
2021-02-18Description
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 14-Day RSI | 23.85 | |||||
| 12-1 Month Momentum % | -42.05 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -46.2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 59.16 | |||||
| Forward PE Ratio | 51.99 | |||||
| PE Ratio without NRI | 50.86 | |||||
| EV-to-EBIT | 668.41 | |||||
| EV-to-Forward-EBIT | 134.92 | |||||
| EV-to-EBITDA | 668.41 | |||||
| EV-to-Revenue | 3.35 | |||||
| EV-to-Forward-Revenue | 2.25 | |||||
| Earnings Yield (Greenblatt) % | 0.15 | |||||
| FCF Yield % | -10.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
New Horizon Health Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 1,502.079 | ||
| EPS (TTM) (HK$) | 0.239 | ||
| Beta | 0.79 | ||
| Volatility % | 55.86 | ||
| 14-Day RSI | 23.85 | ||
| 14-Day ATR (HK$) | 0.000007 | ||
| 20-Day SMA (HK$) | 14.14 | ||
| 12-1 Month Momentum % | -42.05 | ||
| 52-Week Range (HK$) | 13.76 - 24.8 | ||
| Shares Outstanding (Mil) | 448.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
New Horizon Health Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
New Horizon Health Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
New Horizon Health Ltd Frequently Asked Questions
What is New Horizon Health Ltd(HKSE:06606)'s stock price today?
The current price of HKSE:06606 is HK$14.14. The 52 week high of HKSE:06606 is HK$24.80 and 52 week low is HK$13.76.
When is next earnings date of New Horizon Health Ltd(HKSE:06606)?
The next earnings date of New Horizon Health Ltd(HKSE:06606) is .
Does New Horizon Health Ltd(HKSE:06606) pay dividends? If so, how much?
New Horizon Health Ltd(HKSE:06606) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers